Searched for
ELARA INDIA OPPORTUNITIES FUND LIMITED
Turtlemint Fintech IPO Day 2: Issue subscribed 52%; Check GMP and other key detailsTurtlemint Fintech Solutions IPO: The issue, comprising a fresh issue of ₹660.7 crore and an offer-for-sale of ₹221.9 crore, is priced at ₹...- OnFinance AI founder criticises All In Capital for not investing, apologisesBengaluru fintech founder Anuj Srivastava apologised after publicly criticising venture firm All In Capital for not investing in his startu...
- BHEL, Coal India investing Rs 25,000 crore in Odisha coal gasification project: G Kishan ReddyA significant Rs 25,000 crore investment by BHEL and Coal India Limited is set to transform Odisha's coal sector. This ambitious project wi...
- World Bank clears $1.5 billion package to boost India's structural reforms, private sector jobsThe World Bank has approved a $1.5 billion financing package for India, aimed at accelerating structural reforms and stimulating private se...
- Turtlemint Fintech's Rs 883 crore IPO opens for subscription. Check brokerage review, GMP and other detailsThe IPO comprises a fresh issue worth Rs 660.7 crore and an offer for sale (OFS) of Rs 221.9 crore, taking the total issue size to about Rs...
- Buy, Sell or Hold: Morgan Stanley raises target price on NYKAA; Elara Capital maintains buy on Devyani InternationalBrokerage views on Indian equities are mixed as Morgan Stanley raises Nykaa's target price on ambitious FY30 growth plans. Conversely, conc...
- Nifty upside limited, but stock-specific opportunities remain: Pramod AmtheIndian equities face headwinds from inflation and monsoon uncertainty, yet opportunities exist. Pramod Amthe of InCred Capital highlights s...
- The 30% smallcap tilt: How Abakkus Flexi Cap Fund is positioning for the next rallyAbakkus Mutual Fund is strategically allocating 30% to smallcaps within its Flexi Cap Fund, identifying mispriced opportunities despite str...
- India, Sri Lanka collaborate to strengthen trade interactions through local currency settlement initiativesIndia and Sri Lanka are exploring ways to settle trade using their own currencies. This move aims to cut transaction costs and shield busin...
- India's export outlook is challenging for FY27, but worst is over: Elara SecuritiesIndia's export outlook remains challenging in FY27 amid moderating global demand and elevated electronics imports, but the worst phase appe...
- India's telecom ARPU to grow 7% CAGR through FY29; narrowing tariff gap with global markets: ReportIndia's telecom sector is set for a multi-year growth phase. Average Revenue Per User (ARPU) is projected to grow at 7% annually from FY26 ...
- India's REIT and InvIT market to attract Rs 11.6 trillion new investments; AUM may double to Rs 20 trillion by 2030: Avendus CapitalIndia’s REIT and InvIT market could attract an additional Rs 11.6 trillion in investments by 2030, taking total assets under management bey...
- India’s first clean economy index fund is here: Should you invest?India's green transition is accelerating, and the Motilal Oswal BSE Clean Environment Index Fund offers a unique passive investment route. ...
- Schneider shares hit upper circuit on parent co's AI dealSchneider Electric Infrastructure shares saw a significant jump. This followed an announcement by its French parent, Schneider Electric. Th...
- NFO Alert: Kotak Mutual Fund launches first SIF with hybrid long-short strategyKotak Mutual Fund has launched its maiden Specialised Investment Fund (SIF), the Kotak Infinity Hybrid Long-Short Fund, marking its entry i...
- Lenskart shares in focus as Goldman Sachs, Morgan Stanley, others purchase stake in Rs 1,960 crore block dealLenskart Solutions saw significant stake activity as marquee investors bought Rs 1,960 crore in a block deal, with Platinum Jasmine A 2018 ...
- Goldman Sachs, Morgan Stanley and others buy stake in Rs 1,960 crore Lenskart block dealADIA-backed Platinum Jasmine A 2018 Trust sold a 2.3% stake in Lenskart through a Rs 1,960 crore block deal. The transaction attracted stro...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- ADIA to sell Rs 1,944 crore Lenskart stake days after SoftBank exitAbu Dhabi Investment Authority (ADIA) is set to divest up to 2.3% of its stake in eyewear retailer Lenskart for approximately Rs 1,944 cror...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
Load More
